当前位置: X-MOL 学术EMBO Mol. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Publisher Correction: Novel immunotherapeutics against LGR5 to target multiple cancer types.
EMBO Molecular Medicine ( IF 9.0 ) Pub Date : 2024-11-01 , DOI: 10.1038/s44321-024-00139-6
Hung-Chang Chen,Nico Mueller,Katherine Stott,Chrysa Kapeni,Eilidh Rivers,Carolin M Sauer,Flavio Beke,Stephen J Walsh,Nicola Ashman,Louise O'Brien,Amir Rafati Fard,Arman Ghodsinia,Changtai Li,Fadwa Joud,Olivier Giger,Inti Zlobec,Ioana Olan,Sarah J Aitken,Matthew Hoare,Richard Mair,Eva Serrao,James D Brenton,Alicia Garcia-Gimenez,Simon E Richardson,Brian Huntly,David R Spring,Mikkel-Ole Skjoedt,Karsten Skjødt,Marc de la Roche,Maike de la Roche



中文翻译:


出版商更正:针对 LGR5 的新型免疫疗法,靶向多种癌症类型。


更新日期:2024-09-25
down
wechat
bug